Newer drugs for asthma
- PMID: 15345874
- DOI: 10.1007/BF02730663
Newer drugs for asthma
Abstract
Several new drugs have resulted from innovative pharmacological and immunomodulatory approaches towards treatment of asthma. Diverse therapeutic targets have provided new agents. The new classes of drugs available are newer "on site activated inhaled corticisteroids" and soft steroids, anti IgE compounds, leukotriene inhibitors and single isomer agents which are available for clinical use. Anti interleukin agents and phosphodiesterase inhibitors are in the stage of clinical trials. Antisense therapy and pharmacogenetics are the on horizon for treatment of asthma.
Similar articles
-
Asthma. New therapeutic approaches.Br Med Bull. 1992 Jan;48(1):231-47. doi: 10.1093/oxfordjournals.bmb.a072538. Br Med Bull. 1992. PMID: 1352169 Review.
-
Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.Expert Opin Pharmacother. 2001 Jan;2(1):47-65. doi: 10.1517/14656566.2.1.47. Expert Opin Pharmacother. 2001. PMID: 11336568 Review.
-
Emerging therapeutic options for asthma.Am J Manag Care. 2011 Apr;17 Suppl 3:S82-9. Am J Manag Care. 2011. PMID: 21761958 Review.
-
Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.Mol Diagn Ther. 2007;11(2):97-104. doi: 10.1007/BF03256228. Mol Diagn Ther. 2007. PMID: 17397245 Review.
-
Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma.Pharmacol Res. 2022 Jul;181:106280. doi: 10.1016/j.phrs.2022.106280. Epub 2022 May 31. Pharmacol Res. 2022. PMID: 35661709